Folly Launches Innovative Hair Health Gummy

Folly has announced the launch of its biotech-powered hair supplement, the first of its kind incorporating a pill-strength dosage in gummy form. This marks a significant development in the supplement industry, where underdosing and consistency issues have been persistent challenges. The new product features over 30 clinically proven ingredients, delivered through a unique microencapsulation technology called Folly Microspheres, developed by Genecis Bio.

Traditional hair supplements often suffer from inadequate dosing and user difficulties with pill formats. Folly aims to overcome these with a formulation that significantly exceeds the typical dosages found in gummies, while maintaining ease of use and flavor. A consumer study indicated substantial improvements in hair health among users within 30 days.

Folly's launch is backed by an investment from Khosla Ventures, set to facilitate its expansion in the U.S., U.K., and further into Europe and Asia. This initiative introduces a novel approach to the hair supplement market, applying drug-delivery science to ensure effective nutrient absorption.